Adrenergic alpha-Agonists
"Adrenergic alpha-Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that selectively bind to and activate alpha adrenergic receptors.
| Descriptor ID |
D000316
|
| MeSH Number(s) |
D27.505.519.625.050.100.100 D27.505.696.577.050.100.100
|
| Concept/Terms |
Adrenergic alpha-Agonists- Adrenergic alpha-Agonists
- Adrenergic alpha Agonists
- alpha-Agonists, Adrenergic
- Receptor Agonists, Adrenergic alpha
- Receptor Agonists, alpha-Adrenergic
- Agonists, alpha-Adrenergic Receptor
- Receptor Agonists, alpha Adrenergic
- alpha-Adrenergic Receptor Agonist
- Agonist, alpha-Adrenergic Receptor
- Receptor Agonist, alpha-Adrenergic
- alpha Adrenergic Receptor Agonist
- alpha-Adrenergic Receptor Agonists
- alpha Adrenergic Receptor Agonists
- Adrenergic alpha-Agonist
- Adrenergic alpha Agonist
- alpha-Agonist, Adrenergic
- alpha-Adrenergic Agonist
- Agonist, alpha-Adrenergic
- alpha Adrenergic Agonist
- alpha-Adrenergic Agonists
- Agonists, alpha-Adrenergic
- alpha Adrenergic Agonists
- Adrenergic alpha-Receptor Agonist
- Adrenergic alpha Receptor Agonist
- Agonist, Adrenergic alpha-Receptor
- alpha-Receptor Agonist, Adrenergic
- Adrenergic alpha-Receptor Agonists
- Adrenergic alpha Receptor Agonists
- Agonists, Adrenergic alpha-Receptor
- alpha-Receptor Agonists, Adrenergic
|
Below are MeSH descriptors whose meaning is more general than "Adrenergic alpha-Agonists".
Below are MeSH descriptors whose meaning is more specific than "Adrenergic alpha-Agonists".
This graph shows the total number of publications written about "Adrenergic alpha-Agonists" by people in this website by year, and whether "Adrenergic alpha-Agonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 1 | 2 |
| 2005 | 0 | 2 | 2 |
| 2007 | 1 | 1 | 2 |
| 2009 | 1 | 1 | 2 |
| 2010 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adrenergic alpha-Agonists" by people in Profiles.
-
Fantasia HC. A Nonhormonal Treatment for Moderate to Severe Vasomotor Symptoms of Menopause. Nurs Womens Health. 2016 Oct - Nov; 20(5):511-518.
-
Schlachetzki JC, Fiebich BL, Haake E, de Oliveira AC, Candelario-Jalil E, Heneka MT, H?ll M. Norepinephrine enhances the LPS-induced expression of COX-2 and secretion of PGE2 in primary rat microglia. J Neuroinflammation. 2010 Jan 11; 7:2.
-
Shields AD, Wang Q, Winder DG. alpha2A-adrenergic receptors heterosynaptically regulate glutamatergic transmission in the bed nucleus of the stria terminalis. Neuroscience. 2009 Sep 29; 163(1):339-51.
-
Lu R, Li Y, Zhang Y, Chen Y, Shields AD, Winder DG, Angelotti T, Jiao K, Limbird LE, Zhou Y, Wang Q. Epitope-tagged receptor knock-in mice reveal that differential desensitization of alpha2-adrenergic responses is because of ligand-selective internalization. J Biol Chem. 2009 May 08; 284(19):13233-43.
-
Ziedonis DM, Amass L, Steinberg M, Woody G, Krejci J, Annon JJ, Cohen AJ, Waite-O'Brien N, Stine SM, McCarty D, Reid MS, Brown LS, Maslansky R, Winhusen T, Babcock D, Brigham G, Muir J, Orr D, Buchan BJ, Horton T, Ling W. Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence. Drug Alcohol Depend. 2009 Jan 01; 99(1-3):28-36.
-
McElligott ZA, Winder DG. Alpha1-adrenergic receptor-induced heterosynaptic long-term depression in the bed nucleus of the stria terminalis is disrupted in mouse models of affective disorders. Neuropsychopharmacology. 2008 Sep; 33(10):2313-23.
-
Goddeau RP, Silverman SB, Sims JR. Dexmedetomidine for the treatment of paroxysmal autonomic instability with dystonia. Neurocrit Care. 2007; 7(3):217-20.
-
Egli RE, Kash TL, Choo K, Savchenko V, Matthews RT, Blakely RD, Winder DG. Norepinephrine modulates glutamatergic transmission in the bed nucleus of the stria terminalis. Neuropsychopharmacology. 2005 Apr; 30(4):657-68.
-
Moore TL, Schettler SP, Killiany RJ, Herndon JG, Luebke JI, Moss MB, Rosene DL. Cognitive impairment in aged rhesus monkeys associated with monoamine receptors in the prefrontal cortex. Behav Brain Res. 2005 May 28; 160(2):208-21.
-
Vanhoose AM, Ritchie MD, Winder DG. Regulation of cAMP levels in area CA1 of hippocampus by Gi/o-coupled receptors is stimulus dependent in mice. Neurosci Lett. 2004 Nov 03; 370(1):80-3.